SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-188291
Filing Date
2022-07-06
Accepted
2022-07-06 08:43:33
Documents
15
Period of Report
2022-06-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d370202d8k.htm   iXBRL 8-K 36461
2 EX-3.1 d370202dex31.htm EX-3.1 3034
3 EX-99.1 d370202dex991.htm EX-99.1 13391
7 GRAPHIC g370202g87j00.jpg GRAPHIC 2439
  Complete submission text file 0001193125-22-188291.txt   187509

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220630.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220630_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220630_pre.xml EX-101.PRE 11268
9 EXTRACTED XBRL INSTANCE DOCUMENT d370202d8k_htm.xml XML 3432
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 221067466
SIC: 3841 Surgical & Medical Instruments & Apparatus